Cardiopulmonary Stress Testing Systems Market Cardiopulmonary Stress Testing Systems Market : ToC


Cardiopulmonary Stress Testing Systems Market

Cardiopulmonary Stress Testing Systems Market (Product Type - Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT); End-user - Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL1530
  • Published On : Nov 2017
  • No. of Pages : 200
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectivesv
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
                     4.4.1.1. Rising awareness among end-users about accurate assessment of cardiovascular diseases due to new monitoring technologies is significantly enhancing the diagnosis rate
                     4.4.1.2. Growing geriatric population propels adoption of preventive disease-monitoring products
            4.4.2. Restraints
                     4.4.2.1. Shutdown of Chalk River resulting in shortage of Tc-99 m and reduction in the number of SPECT procedures
                     4.4.2.2. Implementation of legal provisions that promote cost containment/cost-cutting strategies
            4.4.3. Opportunity
     4.5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, 2015–2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s Five Force Analysis
     4.7. Market Outlook
     4.8. Regulatory Scenarios
     4.9. Cardiovascular Diseases Prevalence, by Region
     4.10. Applied SWOT Analysis

5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By Product Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product Type, 2015–2025
            5.4.1. Cardiopulmonary Exercise Testing (CPET) Systems
            5.4.2. Stress ECG
            5.4.3. Pulse Oximeters
            5.4.4. Stress Blood Pressure Monitors
            5.4.5. Single-Photon Emission Computed Tomography (SPECT)
     5.5. Product Type Comparison Matrix
     5.6. Market Attractiveness By Product Type 

6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By End-user 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By End-user, 2015–2025
            6.4.1. Hospitals
            6.4.2. Specialty Clinics/Cardiology Clinics
            6.4.3. Ambulatory Surgical Centers
            6.4.4. Diagnostic Centers
     6.5. Market Attractiveness By End-user 

7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Policies and Regulations
     7.3. Market Value Forecast By Region
            7.3.1. North America 
            7.3.2. Europe 
            7.3.3. Asia Pacific 
            7.3.4. Latin America 
            7.3.5. Middle East and Africa 
     7.4. Market Attractiveness By Country/Region

8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
     8.1. Introduction
            8.1.1. Key Findings
            8.1.2. Key Trends
     8.2. Market Value Forecast By Product Type, 2015–2025
            8.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
            8.2.2. Stress ECG
            8.2.3. Pulse Oximeters
            8.2.4. Stress Blood Pressure Monitors
            8.2.5. Single-Photon Emission Computed Tomography (SPECT)
     8.3. Market Value Forecast By End-user, 2015–2025
            8.3.1. Hospitals
            8.3.2. Specialty Clinics/Cardiology Clinics
            8.3.3. Ambulatory Surgical Centers
            8.3.4. Diagnostic Centers
     8.4. Market Value Forecast By Country, 2015–2025
            8.4.1. U.S.
            8.4.2. Canada
     8.5. Market Attractiveness Analysis 
            8.5.1. By Product Type 
            8.5.2. By End-user 
            8.5.3. By Country

9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Key Trends
     9.2. Market Value Forecast By Product Type, 2015–2025
            9.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
            9.2.2. Stress ECG
            9.2.3. Pulse Oximeters
            9.2.4. Stress Blood Pressure Monitors
            9.2.5. Single-Photon Emission Computed Tomography (SPECT)
     9.3. Market Value Forecast By End-user, 2015–2025
            9.3.1. Hospitals
            9.3.2. Specialty Clinics/Cardiology Clinics
            9.3.3. Ambulatory Surgical Centers
            9.3.4. Diagnostic Centers
     9.4. Market Value Forecast By Country/Sub-region, 2015–2025
            9.4.1. U.K.
            9.4.2. Germany
            9.4.3. France
            9.4.4. Italy
            9.4.5. Spain
            9.4.6. Russia
            9.4.7. Rest of Europe
     9.5. Market Attractiveness Analysis 
            9.5.1. By Product Type 
            9.5.2. By End-user 
            9.5.3. By Country/Sub-region

10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Key Trends
     10.2. Market Value Forecast By Product Type, 2015–2025
            10.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
            10.2.2. Stress ECG
            10.2.3. Pulse Oximeters
            10.2.4. Stress Blood Pressure Monitors
            10.2.5. Single-Photon Emission Computed Tomography (SPECT)
     10.3. Market Value Forecast By End-user, 2015–2025
            10.3.1. Hospitals
            10.3.2. Specialty Clinics/Cardiology Clinics
            10.3.3. Ambulatory Surgical Centers
            10.3.4. Diagnostic Centers
     10.4. Market Value Forecast By Country/Sub-region, 2015–2025
            10.4.1. India
            10.4.2. China
            10.4.3. Japan
            10.4.4. Australia & New Zealand
            10.4.5. Rest of Asia Pacific
     10.5. Market Attractiveness Analysis 
            10.5.1. By Product Type 
            10.5.2. By End-user 
            10.5.3. By Country/Sub-region

11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Key Trends
     11.2. Market Value Forecast By Product Type, 2015–2025
            11.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
            11.2.2. Stress ECG
            11.2.3. Pulse Oximeters
            11.2.4. Stress Blood Pressure Monitors
            11.2.5. Single-Photon Emission Computed Tomography (SPECT)
     11.3. Market Value Forecast By End-user, 2015–2025
            11.3.1. Hospitals
            11.3.2. Specialty Clinics/Cardiology Clinics
            11.3.3. Ambulatory Surgical Centers
            11.3.4. Diagnostic Centers
     11.4. Market Value Forecast By Country/Sub-region, 2015–2025
            11.4.1. Brazil
            11.4.2. Mexico
            11.4.3. Rest of Latin America
     11.5. Market Attractiveness Analysis 
            11.5.1. By Product Type 
            11.5.2. By End-user 
            11.5.3. By Country/Sub-region

12. Middle East and Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market Value Forecast By Product Type, 2015–2025
            12.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
            12.2.2. Stress ECG
            12.2.3. Pulse Oximeters
            12.2.4. Stress Blood Pressure Monitors
            12.2.5. Single-Photon Emission Computed Tomography (SPECT)
     12.3. Market Value Forecast By End-user, 2015–2025
            12.3.1. Hospitals
            12.3.2. Specialty Clinics/Cardiology Clinics
            12.3.3. Ambulatory Surgical Centers
            12.3.4. Diagnostic Centers
     12.4. Market Value Forecast By Country/Sub-region, 2015–2025
            12.4.1. South Africa
            12.4.2. GCC Countries
            12.4.3. Israel
            12.4.4. Rest of Middle East and Africa
     12.5. Market Attractiveness Analysis 
            12.5.1. By Product Type 
            12.5.2. By End-user 
            12.5.3. By Country/Sub-region

13. Competition Landscape
     13.1. Market Player – Competition Matrix (By Tier and Size of companies)
     13.2. Market Share Analysis By Company (2016)
     13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.3.1. Koninklijke Philips N.V.
                     13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.1.2 Financial Overview
                     13.3.1.3 Product Portfolio
                     13.3.1.4 SWOT Analysis
                     13.3.1.5 Strategic Overview
            13.3.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.) 
                     13.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.2.2 Financial Overview
                     13.3.2.3 Product Portfolio
                     13.3.2.4 SWOT Analysis
                     13.3.2.5 Strategic Overview
            13.3.3. General Electric Company (GE Healthcare)
                     13.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.3.2 Financial Overview
                     13.3.3.3 Product Portfolio
                     13.3.3.4 SWOT Analysis
                     13.3.3.5 Strategic Overview
            13.3.4. MGC Diagnostics Corporation 
                     13.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.4.2 Financial Overview
                     13.3.4.3 Product Portfolio
                     13.3.4.4 SWOT Analysis
                     13.3.4.5 Strategic Overview
            13.3.5. OSI Systems, Inc. (Spacelabs Healthcare)
                     13.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.5.2 Financial Overview
                     13.3.5.3 Product Portfolio
                     13.3.5.4 SWOT Analysis
                     13.3.5.5 Strategic Overview
            13.3.6. Masimo 
                     13.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.6.2 Financial Overview
                     13.3.6.3 Product Portfolio
                     13.3.6.4 SWOT Analysis
                     13.3.6.5 Strategic Overview
            13.3.7. NIHON KOHDEN CORPORATION 
                     13.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.7.2 Financial Overview
                     13.3.7.3 Product Portfolio
                     13.3.7.4 SWOT Analysis
                     13.3.7.5 Strategic Overview
            13.3.8. COSMED 
                     13.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.8.2 Financial Overview
                     13.3.8.3 Product Portfolio
                     13.3.8.4 SWOT Analysis
                     13.3.8.5 Strategic Overview 
            13.3.9. Halma plc (SunTech Medical, Inc.) 
                     13.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.9.2 Financial Overview
                     13.3.9.3 Product Portfolio
                     13.3.9.4 SWOT Analysis
                     13.3.9.5 Strategic Overview
            13.3.10. Schiller AG 
                     13.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.10.2 Financial Overview
                     13.3.10.3 Product Portfolio
                     13.3.10.4 SWOT Analysis
                     13.3.10.5 Strategic Overview
            13.3.11. Vyaire Medical, Inc. 
                     13.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
                     13.3.11.2 Financial Overview
                     13.3.11.3 Product Portfolio
                     13.3.11.4 SWOT Analysis
                     13.3.11.5 Strategic Overview

14. Key Take Away

List of Tables

Table 01: Medical Device Classification as per U.S. FDA
Table 02: Code of Federal Regulations, by Type of Device
Table 03: Supplements for Pre-market Approval, by Type of Supplement, 1986–1997
Table 04: Medical Device Classification as per European Commission (EC)
Table 05: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 06: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Cardiopulmonary Stress Testing Systems Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 12: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 13: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 14: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 15: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 16: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 20: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 22: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–202

List of Figures

Figure 01: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, 2015–2025
Figure 02: Global Cardiopulmonary Stress Testing Systems Market Value Share, by Product (2016)
Figure 03: Global Cardiopulmonary Stress Testing Systems Market Value Share, by Region (2016)
Figure 04: Global Cardiopulmonary Stress Testing Systems Market Value Share, by End-user (2016)
Figure 05: FDA Review Process for 2016
Figure 06: Deaths per Mn Population Caused by Cardiovascular Diseases, by Country, 2012
Figure 07: Global Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type, 2017 and 2025
Figure 08: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiopulmonary Exercise Testing (CPET) Systems, 2015–2025
Figure 09: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress ECG, 2015–2025
Figure 10: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pulse Oximeters, 2015–2025
Figure 11: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress Blood Pressure Monitors, 2015–2025
Figure 12: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single-Photon Emission Computed Tomography (SPECT), 2015–2025
Figure 13: Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2017–2025
Figure 14: Global Cardiopulmonary Stress Testing Systems Market Value Share, by End-user, 2017 and 2025
Figure 15: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
Figure 16: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Clinics/ Cardiology Clinics, 2015–2025
Figure 17: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2015–2025
Figure 18: Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2015–2025
Figure 19: Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by End-user, 2017–2025
Figure 20: Global Cardiopulmonary Stress Testing Systems Market Value Share, by Region, 2017 and 2025
Figure 21: Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by Region, 2017–2025
Figure 22: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 23: North America Cardiopulmonary Stress Testing Systems Market Value Share, by Country, 2017 and 2025
Figure 24: North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country, 2017–2025
Figure 25: North America Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type, 2017 and 2025
Figure 26: North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2017–2025
Figure 27: North America Cardiopulmonary Stress Testing Systems Market Value Share, by End-user, 2017 and 2025
Figure 28: North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by End-user, 2017–2025
Figure 29: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 30: Europe Cardiopulmonary Stress Testing Systems Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 31: Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 32: Europe Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type, 2017 and 2025
Figure 33: Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2017–2025
Figure 34: Europe Cardiopulmonary Stress Testing Systems Market Value Share, by End-user, 2017 and 2025
Figure 35: Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by End-user, 2017–2025
Figure 36: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 37: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 38: Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 39: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type, 2017 and 2025
Figure 40: Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2017–2025
Figure 41: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share, by End-user, 2017 and 2025
Figure 42: Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by End-user, 2017–2025
Figure 43: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 44: Latin America Cardiopulmonary Stress Testing Systems Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 45: Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 46: Latin America Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type, 2017 and 2025
Figure 47: Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2017–2025
Figure 48: Latin America Cardiopulmonary Stress Testing Systems Market Value Share, by End-user, 2017 and 2025
Figure 49: Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by End-user, 2017–2025
Figure 50: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 51: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 52: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 53: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type, 2017 and 2025
Figure 54: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2017–2025
Figure 55: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share, by End-user, 2017 and 2025
Figure 56: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by End-user, 2017–2025
Figure 57: Global Cardiopulmonary Stress Testing Systems Market Share, by Company, 2016 
Figure 58: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016, Koninklijke Philips N.V. 
Figure 59: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016, Koninklijke Philips N.V. 
Figure 60: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016, Koninklijke Philips N.V. 
Figure 61: Breakdown of Net Sales (%), by Region, 2016, Koninklijke Philips N.V. 
Figure 62: Breakdown of Net Sales (%), by Business Segment, 2016, Koninklijke Philips N.V. 
Figure 63: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.) 
Figure 64: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 65: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.) 
Figure 66: Breakdown of Net Sales (%), by Region, 2016 (Hill-Rom Holdings, Inc.)
Figure 67: Breakdown of Net Sales (%), by Business Segment, 2016 (Hill-Rom Holdings, Inc.)
Figure 68: Breakdown of Net Sales (%), by Region, 2015 (Welch Allyn)
Figure 69: Breakdown of Net Sales (~ %), by Business Segments, 2016 (Mortara Instrument, Inc.)
Figure 70: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016, General Electric Company (GE Healthcare) 
Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, General Electric Company (GE Healthcare) 
Figure 72: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, General Electric Company (GE Healthcare) 
Figure 73: Breakdown of Net Sales (%), by Region, 2016, General Electric Company (GE Healthcare) 
Figure 74: Breakdown of Net Sales (%), by Business Segment, 2016, General Electric Company (GE Healthcare) 
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016, MGC Diagnostics Corporation 
Figure 76: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016, MGC Diagnostics Corporation 
Figure 77: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016, MGC Diagnostics Corporation 
Figure 78: Breakdown of Net Sales (%), by Region, 2016, MGC Diagnostics Corporation 
Figure 79:  Breakdown of Net Sales (%), by Business Segment, 2016, MGC Diagnostics Corporation
Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016, OSI Systems, Inc. (Spacelabs Healthcare) 
Figure 81: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, OSI Systems, Inc. (Spacelabs Healthcare) 
Figure 82: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, OSI Systems, Inc. (Spacelabs Healthcare) 
Figure 83: Breakdown of Net Sales (%), by Region, 2016, OSI Systems, Inc. (Spacelabs Healthcare) 
Figure 84: Breakdown of Net Sales (%), by Business Segment, 2016, OSI Systems, Inc. (Spacelabs Healthcare) 
Figure 85: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016, Masimo 
Figure 86: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, Masimo 
Figure 87: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2016, Masimo 
Figure 88: Breakdown of Net Sales (%), by Region, 2016, Masimo 
Figure 89: Installed Base (Estimated Units) and Y-o-Y Growth (%), 2013–2016, Masimo 
Figure 90: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017, NIHON KOHDEN CORPORATION 
Figure 91: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017, NIHON KOHDEN CORPORATION 
Figure 92: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017, NIHON KOHDEN CORPORATION 
Figure 93: Breakdown of Net Sales (%), by Region, 2017, NIHON KOHDEN CORPORATION 
Figure 94: Breakdown of Net Sales (%), by Business Segment, 2017, NIHON KOHDEN CORPORATION
Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017, Halma plc (SunTech Medical, Inc.)
Figure 96: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017, Halma plc (SunTech Medical, Inc.)
Figure 97: Breakdown of Net Sales (%), by Business Segment, 2017, Halma plc (SunTech Medical, Inc.

.